Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Diabetes Supply (ADS) is a leading national distributor of durable medical equipment (DME) specializing in diabetes management products. The company provides a comprehensive range of supplies, including continuous glucose monitors (CGM), insulin pumps, and traditional blood glucose testing supplies, directly to patients across the United States. ADS focuses on streamlining the procurement process by handling complex insurance processing and offering direct-to-home shipping services. In 2021, the company significantly expanded its market footprint through the acquisition of US MED, another major player in the diabetes supply sector. ADS is currently owned by the private equity firm Court Square Capital Partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advance Diabetic Solution.